Oslo, November 3rd, 2020 – Observe Medical ASA (OSE: OBSERV) today released its presentation of the third quarter 2020, reporting important steps forward in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “With Sippi®, Observe Medical contributes…
Observe Medical ASA invites you to a presentation of the third quarter 2020. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, November 3. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and on the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201103_4 Due to COVID-19 and corresponding…
Observe Medical ASA, October 30, 2020: On October 29, 2020, Observe Medical announced the signing of the final agreement to acquire Sylak AB, a distributor of ICU/anaesthesia products in the Swedish market, for an enterprise value of SEK 6 million (on a cash and debt free basis). All conditions in the agreement is met, and…
Observe Medical ASA, October 29, 2020: Reference is made to Observe Medical’s announcement October 16, 2020 regarding the signing of a letter of intent to acquire Sylak AB, a distributor of ICU/anaesthesia products in the Swedish market, for an enterprise value of SEK 6 million (on a cash and debt free basis). Today, Observe Medical…
Observe Medical ASA, October 16, 2020: Observe Medical ASA (the "Company" or "Observe Medical") has signed a non-binding term sheet including an exclusive right to acquire 100% of the shares in Sylak AB (“Sylak”), a Swedish private limited company, for an agreed enterprise value of SEK 6 million (on a cash and debt free basis)…
Oslo, 4 September 2020: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 31 August 2020 regarding the exercise of employee share options and issue of 171,875 new shares in the Company. The NOK 44,687.50 share capital increase pertaining to the exercise of the employee share options has now…
Oslo, 31 August 2020: The board of directors of Observe Medical ASA (the "Company") has resolved to increase the share capital of the Company following the completion of an exercise period for vested share options. 1. Exercise of employee share options In total 171,875 employee share options were exercised, giving the option holders the right…
Oslo, 18 August 2020 – Observe Medical ASA (OSE: OBSERV) today released its interim report for the second quarter and first half year of 2020. The company’s initial product, Sippi, a unique and proprietary solution for digital automated urine monitoring in hospitals is in an early stage of commercialization. The company confirms its market estimate…
A recently published article demonstrates that the patented Sippcoat® technology, an integrated part of Sippi® system, from Observe Medical, significantly reduces microbial biofilm formation in medical devices, suggesting a new strategy for reducing hospital-acquired infections. The article “Making medical devices safer: impact of plastic and silicone oil on microbial biofilm formation” was recently published in…
Observe Medical ASA invites you to a presentation of the second quarter and first half year of 2020 figures. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, August 18th. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link:…
Oslo 7 August 2020 – Observe Medical ASA (OSE: OBSERV), today announces it has entered into an updated distribution agreement and strengthened partnership with SIM Italia S.r.l. for the launch of Sippi® in the Italian market. “We are pleased to announce our strengthened partnership with SIM Italia and the signing of an updated distribution agreement…
(Oslo, 20 July 2020) Notice of exercise of employee share options In connection with the expiry date at 31 March 2020, postponed by the Board of Directors to no later than 30 September 2020, Kathrine Gamborg Andreassen, board member, have at 20 July 2020 given notice that she will exercise a total of 125,000 options…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Reference is made to Observe Medical ASA's (the "Company") stock exchange announcement on 6 July 2020 regarding the final result in the in the rights issue of 4,090,909 new shares in the Company (the "Offer Shares") at a subscription price of NOK 11.00 per share (the "Rights Issue"). Navamedic ASA ("NAVA"), represented at the Company's…
Reference is made to Observe Medical ASA's (the "Company") stock exchange announcement on 6 July 2020 regarding the final result in the in the rights issue of 4,090,909 new shares in the Company (the "Offer Shares") at a subscription price of NOK 11.00 per share (the "Rights Issue"). Ingerø Reiten Investment Company AS ("IRIC"), represented…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Oslo, Norway, 3 July 2020. Primary Insider and CEO, Björn Larsson, has today purchased 17,000 shares in Observe Medical ASA at an average price of NOK 13.27. Following this transaction, Björn Larsson holds 17,000 shares and 120,000 options in Observe Medical ASA. Primary insider and CFO, Per Arne Nygård, has today purchased 18,921 shares in…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Reference is made to the ongoing rights issue of 4,090,909 new shares (the "Offer Shares") at a subscription price of NOK 11.00 per share in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue"). Primary insider, Kathrine Gamborg Andreassen, a member of the Company's…
Observe Medical ASA has today, June 30, 2020, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. Björn Larsson, CEO, Observe Medical ASA Tel.: + 46 76 620 17 25…
Reference is made to the ongoing rights issue of 4,090,909 new shares to a subscription price of NOK 11.00 (the "Offer Shares") in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue").Ingerø Reiten Investment Company AS ("IRIC"), represented at the Company's board of directors…
Reference is made to the ongoing rights issue of 4,090,909 new shares to a subscription price of NOK 11.00 (the "Offer Shares") in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue"). Navamedic ASA ("NAVA"), represented at the Company's board of directors by Kathrine…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
The annual general meeting of Observe Medical ASA (OSE: OBSERV) will be held on Tuesday, June 30 2020 at 14:00 (CET) in the Observe Medical offices in Henrik Ibsens gate 90 (3rd floor), 0255 Oslo. The Notice of the Annual General Meeting is attached. Due to the restrictions caused by Covid-19 and advice from the…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Oslo, 12 May 2020 – Observe Medical ASA (OSE: OBSERV) today released its presentation of the first quarter 2020, including an updated market study indicating a doubling of the potential market value for the company’s first product, Sippi®. The company’s long term revenue ambition for Sippi® is increased accordingly to NOK 500 million. “During the…
Observe Medical ASA invites you to a presentation of the first quarter 2020 figures. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, May 12th. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link: https://channel.royalcast.com/webcast/hegnarmedia/20200512_4/ Representatives from the Company…
Attached Observe Medical ASA`s annual report for 2019. The report is also available on the company's website, www.observemedical.com The annual report was reviewed and approved by the board of directors on 29 April 2020. The final financial statements included in the annual report has no significant changes since the preliminary results for the full year…
Oslo, 19 March 2020 – Observe Medical ASA (OSE: OBSERV) today provides a business update in light of COVID-19. The company reports continued high activity level in operations, and several initiatives in the launch and roll-out of Sippi®. “The evolving COVID-19 situation has serious impact on all aspects of the global society, specifically the healthcare…
Observe Medical ASA, 28 February 2020: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 24 January 2020 regarding the exercise of employee share options and issue of 275,000 new shares in the Company. The NOK 71,500 share capital increase pertaining to the exercise of the employee share options…
Oslo, 25 February 2020 – Observe Medical ASA (OSE: OBSERV) continued implementation of its growth strategy in the fourth quarter of 2019, including the commercialization of its first product Sippi®. “In the fourth quarter of 2019, we have taken important steps in the commercialization of Sippi. In parallel we have strengthened our foundation for value…
Observe Medical ASA invites you to a presentation of the fourth quarter and full year 2019 figures. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, February 25th.
(Oslo, 24 January 2020) Exercise of employee share options In connection with the expiry date at 24 January three employees in Navamedic ASA have exercised a total of 275,000 options in Observe Medical ASA. Employees in Navamedic ASA were granted options in Observe Medical ASA in connection with the demerger of Navamedic ASA’s Medtech division…
Observe Medical ASA Board of Directors has on January 9 2020, as part of a long-term incentive plan, approved granting Björn Larsson (CEO in Observe Medical ASA) 60 000 series A options and 60 000 series B options. Each option, when exercised, will give the right to acquire one share in Observe Medical ASA. The…
Financial calendar for Observe Medical ASA FINANCIAL YEAR 2019 17.04.2020 – Annual Report 03.06.2020 – Annual General Meeting 25.02.2020 – Quarterly Report – Q4 FINANCIAL YEAR 2020 18.08.2020 – Half-yearly Report 12.05.2020 – Quarterly Report – Q1 03.11.2020 – Quarterly Report – Q3 This information is published pursuant to the requirements set out in…
Oslo, 9 December 2019: Observe Medical ASA (“Observe Medical”) today announces that Per Arne Nygård is appointed interim Chief Financial Officer of the company for the period 9 December, 2019 to 1 March, 2020. Per Arne Nygård has been with Navamedic ASA as a consultant since August, 2019. He has held several executive financial positions…
Observe Medical ASA, 1 November 2019: Reference is made to Navamedic ASA's ("NAVA") and Observe Medical ASA's ("Observe Medical") stock exchange announcements dated 30 October 2019 and 31 October 2019, regarding Oslo Børs' approval of Observe Medical's application for listing of its shares on Oslo Axess (the "Listing") and the completion of the demerger of…
Observe Medical ASA, 1 November 2019: On 1 October 2019, the general meeting of Observe Medical ASA (the "Company) resolved to increase the share capital of the Company with NOK 832,000 by issuance of 3,200,000 new shares to Navamedic ASA, each with a nominal value of NOK 0.26, by way of set-off against a receivable…
Reference is made to the announcement from Navamedic ASA 31.10.2019 The shares in Navamedic ASA will today be traded exclusive of rights to consideration shares in Observe Medical ASA.
Observe Medical ASA, 31 October 2019: Reference is made to Navamedic ASA's ("NAVA") previous stock exchange announcements regarding the proposed demerger of NAVA with transfer to Observe Medical ASA (the "Company" or "Observe Medical"). Today, on 31 October 2019, after the close of trading on the Oslo Stock Exchange, completion of the demerger of NAVA…
Navamedic ASA, 31 October 2019: The shares in Navamedic ASA ("NAVA") will today on Thursday 31 October 2019 for the last day trade inclusive of rights to consideration shares in Observe Medical ASA ("Observe Medical") to be distributed in connection with the demerger of NAVA. The demerger, whereby inter alia NAVA's Medtech division is demerged… Observe Medical ASA: Interim report third quarter 2020
Observe Medical ASA : Invitation to third quarter 2020 presentation
Observe Medical ASA – Closing of the transaction to acquire Sylak AB completed.
Observe Medical ASA – Final agreement to acquire Sylak AB signed
Observe Medical ASA – Signs agreement with the intention to acquire Sylak AB
Observe Medical ASA: Registration of share capital increase following exercise of employee share options
Observe Medical ASA: Exercise of share options, resolution to increase the share capital and mandatory notification of trade
Observe Medical ASA: Interim report second quarter and first half year 2020
Observe Medical: Scientific article provides evidence of Sippi® technology reducing microbial biofilm formation – a risk factor for patient infection
Observe Medical ASA : Invitation to second quarter and first half year of 2020 presentation
Observe Medical signs updated distribution agreement for Sippi® in Italy
Observe Medical ASA: Mandatory notification of trades by primary insider
Observe Medical ASA – Registration of share capital increase
Observe Medical ASA – Primary insider notice
Observe Medical ASA – Major shareholding notification and primary insider notice
Observe Medical ASA – Final result of the Rights Issue
Observe Medical ASA – Preliminary results of the Rights Issue
Observe Medical ASA: Primary Insider notification
Observe Medical ASA – The subscription period for the rights issue expires today
Observe Medical ASA – Last day of trading in subscription rights
Observe Medical ASA – Primary insider notice
Observe Medical ASA: Annual General Meeting held
Observe Medical ASA – Primary insider notice
Observe Medical ASA – Primary insider notice
Observe Medical ASA – Investor presentations in connection with the rights issue
Observe Medical ASA – Commencement of the subscription period for the rights issue
Observe Medical ASA – Approval and publication of the prospectus for the rights issue
Observe Medical ASA – Rights issue approved by the extraordinary general meeting
Observe Medical ASA – Correction: Terms of the underwritten rights issue
Updated key information relating to the preferential rights issue
Observe Medical ASA – Terms of the underwritten rights issue
Observe Medical ASA: Notice of Annual General Meeting
OBSERVE MEDICAL ASA: KEY INFORMATION RELATING TO THE PREFERENTIAL RIGHTS ISSUE
OBSERVE MEDICAL ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING – FULLY UNDERWRITTEN RIGHTS ISSUE
Observe Medical ASA: Q1 2020 financial results
Observe Medical ASA : Invitation to first quarter 2020 presentation
Observe Medical ASA: Annual report for 2019
Observe Medical ASA: Business update in light of COVID-19
Observe Medical ASA – Registration of share capital increase following exercise of employee share options
Observe Medical ASA: Q4 2019 financial results
Observe Medical ASA: Invitation to fourth quarter and full year 2019 presentation
Observe Medical ASA: Exercise of employee share options and increased share capital
Share options granted
Financial calendar
Observe Medical ASA: Interim CFO appointed
Observe Medical ASA – Approval and publication of listing prospectus
Observe Medical ASA – Registration of share capital increase following completing of debt conversion
Eks rights to consideration shares in Observe Medical ASA
Completion of the demerger of Navamedic ASA; registration of changes in the share capital of Observe Medical ASA and amendment of articles of association of Observe Medical ASA
Navamedic ASA shares: Last day of trading inclusive of rights to consideration shares in Observe Medical ASA